Get the Stockscreener App
84.47
0.82%
0.69
Amedisys Inc stock is traded at $84.47, with a volume of 2.19M.
It is up +0.82% in the last 24 hours and down -6.14% over the past month.
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
See More
Previous Close:
$83.78
Open:
$84.02
24h Volume:
2.19M
Relative Volume:
4.18
Market Cap:
$2.77B
Revenue:
$2.32B
Net Income/Loss:
$82.93M
P/E Ratio:
1,206.71
EPS:
0.07
Net Cash Flow:
$203.54M
1W Performance:
-1.41%
1M Performance:
-6.14%
6M Performance:
-7.78%
1Y Performance:
-11.11%
1-Day Range:
$82.15
$84.87
1-Week Range:
$82.15
$86.20
52-Week Range:
$82.15
$98.95
Amedisys Inc Stock (AMED) Company Profile
Name
Amedisys Inc
Sector
Industry
Phone
(225) 292-2031
Address
3854 AMERICAN WAY, BATON ROUGE, LA
Compare AMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMED
Amedisys Inc
|
84.47 | 2.77B | 2.32B | 82.93M | 203.54M | 2.52 |
|
HCA
Hca Healthcare Inc
|
303.62 | 76.91B | 69.62B | 5.93B | 5.88B | 22.27 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.81 | 13.39B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
151.85 | 12.46B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
129.46 | 12.31B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
180.11 | 11.88B | 15.42B | 1.03B | 956.84M | 15.02 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-01-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-07-23 | Downgrade | Truist | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Mar-13-23 | Initiated | Barclays | Equal Weight |
| Oct-27-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-02-22 | Downgrade | UBS | Neutral → Sell |
| Jun-29-22 | Initiated | Stifel | Hold |
| Jun-21-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-01-22 | Upgrade | UBS | Sell → Neutral |
| Feb-25-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Feb-25-22 | Reiterated | Credit Suisse | Outperform |
| Feb-25-22 | Reiterated | Oppenheimer | Outperform |
| Feb-25-22 | Reiterated | RBC Capital Mkts | Outperform |
| Feb-25-22 | Reiterated | Raymond James | Outperform |
| Feb-25-22 | Reiterated | Truist | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-24-21 | Initiated | UBS | Sell |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-10-21 | Reiterated | The Benchmark Company | Buy |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-20-20 | Resumed | Barclays | Overweight |
| Jul-30-20 | Reiterated | The Benchmark Company | Buy |
| Jun-18-20 | Upgrade | The Benchmark Company | Hold → Buy |
| May-07-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-09-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Jan-17-20 | Initiated | Credit Suisse | Outperform |
| Nov-01-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-22-19 | Resumed | Stephens | Equal-Weight |
| Sep-17-19 | Initiated | Deutsche Bank | Buy |
| May-02-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-14-18 | Initiated | Barclays | Equal Weight |
| Nov-16-18 | Initiated | UBS | Neutral |
| Oct-30-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Jul-03-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-19-18 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Nov-09-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-08-17 | Reiterated | Mizuho | Buy |
| Nov-02-17 | Upgrade | The Benchmark Company | Hold → Buy |
| Aug-21-17 | Initiated | BofA/Merrill | Neutral |
View All
Amedisys Inc Stock (AMED) Latest News
Amedisys stock touches 52-week low at $84.05 amid market shifts - Investing.com Canada
Amedisys (NASDAQ:AMED) Hits New 12-Month LowTime to Sell? - MarketBeat
Amedisys stock touches 52-week low at $84.05 amid market shifts By Investing.com - Investing.com South Africa
Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys - MSN
Amedisys Goes Red - AOL
State Street Corp Reduces Stock Holdings in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Justice Department sues to block UnitedHealth’s $3.3 billion Amedisys purchase - MSN
75,000 Shares in Amedisys, Inc. (NASDAQ:AMED) Bought by Oddo BHF Asset Management Sas - MarketBeat
National Bank of Canada FI Raises Holdings in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Quantinno Capital Management LP Grows Stock Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Amedisys (AMED) Down 12.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
UnitedHealthcare CEO Fatally Shot a Month After US DOJ Sues Parent Company's £2.59B Takeover of Amedisys - MSN
Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Sand Grove Capital Management LLP - MarketBeat
26,619 Shares in Amedisys, Inc. (NASDAQ:AMED) Acquired by Quarry LP - MarketBeat
Melqart Asset Management UK Ltd Has $26.63 Million Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Murchinson Ltd. Has $10.17 Million Stake in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Holocene Advisors LP Acquires 62,953 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Amedisys stock touches 52-week low at $88.72 amid market shifts By Investing.com - Investing.com South Africa
Charles Schwab Investment Management Inc. Boosts Stake in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Amedisys stock touches 52-week low at $88.72 amid market shifts - Investing.com Nigeria
How Amedisys (AMED) Stock Stands Out in a Strong Industry - MSN
Amedisys is Now Oversold (AMED) - Nasdaq
Amedisys falls as divestiture buyer in UnitedHealth sale gets legal judgement (update) - Seeking Alpha
Amedisys Inc (AMED) Shares Down 3.73% on Dec 3 - GuruFocus.com
Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Bridgewater Associates LP - MarketBeat
Edgestream Partners L.P. Acquires New Shares in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Verition Fund Management LLC Has $11.08 Million Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Quest Partners LLC Has $56,000 Stock Holdings in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Buys 61,512 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports - MSN
DOJ sues UnitedHealth amid $3.3 billion bid to buy home care giant Amedisys - AOL
Citigroup Inc. Grows Stock Holdings in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
DOJ blocks UnitedHealth Group and Amedisys merger - The Ticker
US sues to block UnitedHealth's $3.3 billion purchase of Amedisys - MSN
DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal - MSN
Why The DOJ’s Lawsuit Against The UGH-Amedisys Merger May Not Go Anywhere - Dealbreaker
Why the DOJ’s Lawsuit Against the UGH-Amedisys Merger May Not Go Anywhere - MedCity News
Alpine Associates Management Inc. Sells 420,180 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
DOJ Challenges UnitedHealth And Amedisys Merger - Evrim Ağacı
Amedisys Inc Stock (AMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.79%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):